Market Overview

Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of ACADIA Pharmaceuticals Inc. Investors


Law Offices of Howard G. Smith announces that a class action lawsuit has
been filed on behalf of investors that purchased ACADIA Pharmaceuticals
Inc. ("ACADIA" or the "Company") (NASDAQ: ACAD)
securities between April 29, 2016 and July 9, 2018, inclusive
(the "Class Period"). ACADIA investors have until September 17, 2018 to
file a lead plaintiff motion.

Investors that suffered losses on their ACADIA investments are
encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email to

On April 9, 2018, CNN reported that "[p]hysicians, medical researchers
and other experts told CNN that they worried that [NUPLAZID] had been
approved too quickly, based on too little evidence that it was safe or
effective. And given these mounting reports of deaths, they say that
more needs to be done to assess Nuplazid's true risks." On this news,
ACADIA's share price fell $5.03 per share, or 23.4%, to close at $16.50
per share on April 9, 2018, thereby injuring investors.

The complaint filed in this class action alleges that, throughout the
Class Period, Defendants made materially false and/or misleading
statements, as well as failed to disclose material adverse facts about
the Company's business, operations, and prospects. Specifically,
Defendants failed to disclose: (1) that adverse events and safety
concerns related to NUPLAZID threatened the drug's initial and
continuing FDA approval; (2) that ACADIA engaged in business practices
likely to attract regulatory scrutiny; and (3) that, as a result of the
foregoing, Defendants' statements about ACADIA's business, operations,
and prospects, were materially false and/or misleading and/or lacked a
reasonable basis.

If you purchased shares of ACADIA during the Class Period, have
information or would like to learn more about these claims, or have any
questions concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire, of
Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888)
638-4847, or by email to,
or visit our website at

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

View Comments and Join the Discussion!